Table 4.
Adverse events n (%)
| I: rSK schedule A | II: rSK schedule B | III: Hydrocortisone | |
| n | 170 | 170 | 170 |
| Total subjects with adverse events | 5 (2.9) | 7 (4.1) | 11 (6.5) |
| Events | |||
| Anal pruritus | 2 (1.2) | 4 (2.4) | 2 (1.2) |
| Rectal bleeding | 2 (1.2) | 1 (0.6) | 1 (0.6) |
| Anal fissure | 1 (0.6) | 0 | 3 (1.8) |
| Headache | 1 (0.6) | 2 (1.2) | 0 |
| Anal pain | 0 | 0 | 2 (1.2) |
| Local burning sensation | 1 (0.6) | 0 | 1 (0.6) |
| Tenesmus | 1 (0.6) | 0 | 1 (0.6) |
| Constipation | 0 | 0 | 1 (0.6) |
| Diarrhea | 0 | 0 | 1 (0.6) |
| Discomfort due to mass sensation | 1 (0.6) | 0 | 0 |
| Edema | 0 | 0 | 1 (0.6) |
| Stroke | 0 | 0 | 1 (0.6) |
rSK: Recombinant streptokinase.